H. J. Xu

发表

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

E. Estey, W. Benedict, S. Kornblau, 1994, Blood.

Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

S. Groshen, R. Cote, W. Benedict, 1998, Cancer research.

Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

C. Cordon-Cardo, V. Reuter, W. Benedict, 1997, Cancer research.

Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.

W. Benedict, L. Dubeau, H. J. Xu, 1995, Journal of the National Cancer Institute.

Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.

C. Logothetis, W. Ji, Y. Zhou, 1997, Cancer research.

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

E. Estey, M. Andreeff, W. Benedict, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.

P. Tamboli, M. Amin, M. Linden, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.

W. Benedict, D. Quinlan, A. Davidson, 1994, Journal of the National Cancer Institute.

Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

G E Moore, G. Moore, W. Benedict, 1991, Cancer research.

Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.

S. Maeda, W. Benedict, R. Takahashi, 1991, Cancer research.

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

W. Benedict, S. Aaronson, R. Takahashi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Strategies for approaching retinoblastoma tumor suppressor gene therapy.

H. J. Xu, H. J. Xu, H. J. Xu, 1997, Advances in pharmacology.

Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cells.

M. Andreeff, W. Benedict, S. Kornblau, 1995, Leukemia & lymphoma.

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

E. Estey, M. Andreeff, S. Kornblau, 1992, Cancer research.